
2seventy bio, Inc.
NASDAQ:TSVT
4.95 (USD) • At close March 11, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | 2seventy bio, Inc. |
Symbool | TSVT |
Munteenheid | USD |
Prijs | 4.95 |
Beurswaarde | 255,362,679 |
Dividendpercentage | 0% |
52-weken bereik | 2.29 - 5.99 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Nick Leschly |
Website | https://www.2seventybio.com |
An error occurred while fetching data.
Over 2seventy bio, Inc.
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)